Canandaigua National Trust of Florida’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$15.7M Sell
17,046
-1,667
-9% -$1.69M 12.59% 1
2025
Q4
$20.1M Buy
18,713
+25
+0.1% +$23.9K 12.58% 1
2025
Q3
$14.3M Sell
18,688
-3,048
-14% -$2.27M 11.3% 1
2025
Q2
$16.9M Buy
21,736
+295
+1% +$229K 12.05% 1
2025
Q1
$17.7M Sell
21,441
-281
-1% -$234K 15.61% 1
2024
Q4
$16.8M Sell
21,722
-810
-4% -$671K 13.09% 1
2024
Q3
$20M Buy
+22,532
New +$20.3M 17.16% 1

Other funds holding LLY

Canandaigua National Trust of Florida's LLY Position: Q1 2026 in Review

Canandaigua National Trust of Florida reduced its Eli Lilly (LLY) stake by 8.9% in Q1 2026, selling an estimated $1.69M and leaving 17,046 shares worth $15.7M. The position accounts for 12.59% of the portfolio, ranked #1.

Canandaigua National Trust of Florida first reported a position in LLY in Q3 2024 and has held it in 7 quarters since. The position peaked at $20.1M in Q4 2025. 4,380 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Canandaigua National Trust of Florida held 17,046 shares of Eli Lilly worth $15.7M as of Q1 2026.
  • Canandaigua National Trust of Florida sold 1,667 Eli Lilly shares in Q1 2026, an estimated $1.69M.
  • Eli Lilly made up 12.59% of Canandaigua National Trust of Florida's portfolio in Q1 2026, its #1 holding.
  • Canandaigua National Trust of Florida first reported a position in Eli Lilly in Q3 2024 and has held it in 7 quarters since.
  • Canandaigua National Trust of Florida's Eli Lilly position peaked at $20.1M in Q4 2025.
  • 4,380 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Canandaigua National Trust of Florida's 13F filing for Q1 2026, filed 8 Apr 2026.